SM

Syeda Masum Shabnam

Active Director Managing Director DIN 10814050
DIN 10814050 First appointment Oct 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Syeda Masum Shabnam

Data last updated:

Syeda Masum Shabnam is a Managing Director at Sagum Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10814050
Primary Designation Managing Director
Industry Pharma
First Appointment 19 Oct 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director19 Oct 20242024Active

Board colleagues of Syeda Masum Shabnam

NameDINCompanyDesignation
Kalyani Das Bose10814051Sagum Pharmaceuticals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Sagum Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Syeda Masum Shabnam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Syeda Masum Shabnam

Syeda Masum Shabnam currently holds 1 directorship: Sagum Pharmaceuticals Private Limited (Managing Director, since 19 Oct 2024).

Syeda Masum Shabnam was first appointed on 19 Oct 2024 as Managing Director at Sagum Pharmaceuticals Private Limited.

The current boards of Syeda Masum Shabnam's companies include Kalyani Das Bose (Sagum Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available